Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our 108,000 colleagues serve people in more than 160 countries. Abbott’s portfolio spans the most comprehensive set of solutions, including products and technologies in coronary, cardiac rhythm management, electrophysiology, heart failure, structural heart, and endovascular.
Our breadth of industry-leading technologies, along with our combined team of experts, bring you end-to end solutions and services.
Abbott offers a broad portfolio of devices designed to optimize percutaneous peripheral intervention procedures – self-expanding stents, balloon dilatation catheters, guidewires, and a complete portfolio of Vessel Closure devices, allowing physicians to make optimal treatment choices for each individual patient.
One of the Abbott’s medical device divisions provides Neuromodulation solutions to help patients manage chronic pain more effectively. The Neuromodulation portfolio consists of Spinal Cord Stimulation (SCS), Dorsal Root Ganglion (DRG) Stimulation, and Radiofrequency (RF).
RF therapy offers you and your patients a minimally invasive approach that can be employed early in your patients’ continuum of care. The IonicRFTM Generator continues Abbott’s evolution of RF therapy technologies with the capability to perform a range of procedure types, including:
- Monopolar RF
- Bipolar RF
- Pulsed RF
- Pulsed Dose RF
- SimplicityTM Probe for SI Denervation
The IonicRFTM Generator is lightweight and portable for a comfortable fit within standard procedure rooms.